Citigroup
HOWL icon

Citigroup’s Werewolf Therapeutics HOWL Stock Holding History

Citigroup’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,384
Closed -$2.82K – 5961
2026
Q1 		$2.82K Buy
3,384
+3,383
+338,300% +$2.32K ﹤0.01% 5374
2025
Q4 		$1 Sell
1
-8,660
-100% -$10.5K ﹤0.01% 5972
2025
Q3 		$17.1K Buy
8,661
+8,340
+2,598% +$11.4K ﹤0.01% 4870
2025
Q2 		$350 Sell
321
-21,586
-99% -$22.2K ﹤0.01% 5459
2025
Q1 		$21.3K Sell
21,907
-1,822
-8% -$2.39K ﹤0.01% 5078
2024
Q4 		$35.1K Buy
23,729
+718
+3% +$1.46K ﹤0.01% 5175
2024
Q3 		$48.8K Buy
23,011
+16,220
+239% +$36.9K ﹤0.01% 5031
2024
Q2 		$16.6K Sell
6,791
-64,765
-91% -$311K ﹤0.01% 5045
2024
Q1 		$464K Buy
+71,556
New +$417K ﹤0.01% 3628
2023
Q1 		– Sell
-74
Closed -$152 – 5651
2022
Q4 		$152 Sell
74
-353
-83% -$923 ﹤0.01% 5615
2022
Q3 		$2K Sell
427
-309
-42% -$1.68K ﹤0.01% 5499
2022
Q2 		$3K Sell
736
-1,946
-73% -$8.88K ﹤0.01% 5775
2022
Q1 		$12K Sell
2,682
-5,238
-66% -$36.7K ﹤0.01% 5428
2021
Q4 		$94K Buy
7,920
+7,053
+813% +$106K ﹤0.01% 4762
2021
Q3 		$15K Sell
867
-1,149
-57% -$19.6K ﹤0.01% 5352
2021
Q2 		$35K Buy
+2,016
New +$27.6K ﹤0.01% 4983

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup's HOWL Position: Q2 2026 in Review

Citigroup sold out of Werewolf Therapeutics (HOWL) in Q2 2026, closing a stake of 3,384 shares — an estimated $2.82K sold.

Citigroup first reported a position in HOWL in Q2 2021 and held it in 16 quarters. The position peaked at $464K in Q1 2024. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • Citigroup reported no remaining Werewolf Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 3,384 Werewolf Therapeutics shares in Q2 2026, an estimated $2.82K.
  • Citigroup first reported a position in Werewolf Therapeutics in Q2 2021 and held it in 16 quarters.
  • Citigroup's Werewolf Therapeutics position peaked at $464K in Q1 2024.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.